Detailed results of mechanisms revealed that curcumin combined with 5-FU and oxaliplatin could prevent the growth of CSC-enriched chemo-resistant CRC cells by inhibiting epidermal growth factor receptor (EGFR) and insulin-like growth factor 1 receptor (IGF-1R) signaling pathways. Here, EGFR is linked to colorectal carcinoma.